Randhawa P, Brar R, Nolan S Buprenorphine/naloxone ‘micro-dosing’: an alternate induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market CMAJ, 2019. Link

McWilliams C, Bonnie K, Robinson S, Johnson C, Puyat JH, Klimas J Preliminary results of psychiatric inpatients referred to an addiction medicine consult service J Addict Med, 2019. PubMed

Wood E, Simel D, Klimas J Pain management with opioids in 2019-2020 JAMA, 2019. PubMed

McCrae K, Tobias S, Tupper K, Arredondo J, Henry B, Mema S, Wood E, Ti L Drug checking services at music festivals and events in a Canadian setting Drug Alcohol Depend, 2019. PubMed

Kennedy MC, Klassen D, Dong H, Milloy MJ, Hayashi K, Kerr T Supervised injection facility utilization patterns: a prospective cohort study in Vancouver, Canada Am J Prev Med, 2019. PubMed

Dong H, Kerr T Joint trajectories of heroin use and treatment utilisation: who will benefit in the long term? EClinicalMedicine, 2019. Link

Moazen-Zadeh E, Karamouzian M, Kia H, Salway T, Ferlatte O, Knight R A call for action on overdose among LGBTQ people in North America Lancet Psychiatry, 2019. PubMed

Pilarinos A, Barker B, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T, DeBeck K Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada Addiction, 2019. PubMed

Brar R, Sutherland C, Nolan S Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder BMJ Case Rep, 2019. PubMed

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, DeBeck K, Milloy MJ Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting Liver Int, 2019. PubMed